
NexEos Bio Secures FDA Green Light to Progress NTX-1024 into Phase II/III Clinical Development
NexEos Bio Announces FDA Clearance of IND Application to Proceed to Phase II/III Trial of NTX-1024 in Vernal Keratoconjunctivitis NexEos Bio Vision Health a clinical-stage biopharmaceutical company developing novel therapies…












